Counterweight-Plus: The DiRECT Intervention
Counterweight-Plus is an evidence-based weight management programme for those who require significant weight loss (>15kg) in order to manage high body mass index (BMI) and obesity-associated clinical problems including Type 2 diabetes (T2D).
In the DiRECT trial, 46% of people on Counterweight-Plus achieved remission of T2D at 12months, this increased to 73% for those who had lost ≥10kg and 86% for those who lost ≥15kg.
Lean et al The Lancet December 5, 2017
For more info see www.counterweight.org
Wednesday 14th November 2018
13:45 - 14:00
Product Platform - Hypo Hub